Japan unit of Britain’s Jazz Pharma starts phase III trial of cannabis drug

TOKYO, Dec 15 (Reuters) – The Japanese unit of Britain’s Jazz Pharmaceuticals PLC (JAZZ.O) said on Thursday it had started a phase III trial of a cannabis-based drug for epilepsy.

The trial follows a recommendation by a health ministry panel in September to revise Japan’s drug laws to allow for the importation and use of medical marijuana products. read more

Jazz’s GW Pharma said it had administered the first dose to a patient in a late-stage trial expected to involve 84 participants, testing the efficacy and safety of the drug, Epidiolex.

Read more at

https://www.reuters.com/business/healthcare-pharmaceuticals/japan-unit-britains-jazz-pharma-starts-phase-iii-trial-cannabis-drug-2022-12-15/

Authorized Retailers and Dealers for over 200 Brands with over 5,500 Marijuana Strains Cannabis Seeds Outlet UK is becoming one of the best seed banks...

 Seed / Featured

The Friendliest Headshop on the Planet! A leading provider of the coolest, best bongs, pipes, vapes and paraphernalia. Water Pipes Hand Pipes Vaporizers Parts and...

 Vapes and Carts / Featured

Are you looking for an online shop where you can always find high-quality THC gummies and other hemp products? We invite you to browse the...

 CBD / Featured

Certified organic CBD oil, multivitamins, vegan skin care and premium supplements for beauty and wellbeing. for the Ageless is a UK store specialising in CBD...

 CBD / Featured

Page 1 of 3